Ce Ro Therapeutics, Inc. announced it raised $43.2 Million in an initial filing from an offering of $43.2 Million

Company

Location

About

At CERo, we are expanding the armamentarium of engineered cell therapies to create a whole new class of innovative medicines for oncology. Armed with an understanding of cellular clearance and molecular immunology, we engineer cells to engage new and complementary cell elimination pathways to enable deeper and more sustained clinical responses to maximize wellness.